Complementary Stimulation of Hepatobiliary Transport and Detoxification Systems by Rifampicin and Ursodeoxycholic Acid in Humans
- 31 August 2005
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 129 (2) , 476-485
- https://doi.org/10.1053/j.gastro.2005.05.009
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver diseaseClinics in Liver Disease, 2004
- Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the pastissues for the futureJournal of Hepatology, 2000
- Use of Rifampin for Severe Pruritus in Children with Chronic CholestasisJournal of Pediatric Gastroenterology and Nutrition, 1999
- Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysisThe Lancet, 1999
- Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosisGastroenterology, 1997
- Effects of long-term rifampicin administration in primary biliary cirrhosisGastroenterology, 1992
- Treatment of pruritus of primary biliary cirrhosis with rifampinDigestive Diseases and Sciences, 1991
- COMPARISON OF RIFAMPICIN WITH PHENOBARBITONE FOR TREATMENT OF PRURITUS IN BILIARY CIRRHOSISThe Lancet, 1989
- Treatment of pruritus in primary biliary cirrhosis with rifampinGastroenterology, 1988
- Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosisEuropean Journal of Clinical Pharmacology, 1985